TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT
Stanford University
Stanford University
Thomas Jefferson University
University of Alabama at Birmingham
University of Turin, Italy
Ohio State University Comprehensive Cancer Center
University of Rochester
City of Hope Medical Center
University of Washington
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
City of Hope Medical Center
Massachusetts General Hospital
Dartmouth-Hitchcock Medical Center
City of Hope Medical Center
Dana-Farber Cancer Institute
MPN Research Foundation
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Chicago
City of Hope Medical Center
City of Hope Medical Center
Thomas Jefferson University
Thomas Jefferson University
UNC Lineberger Comprehensive Cancer Center
Mayo Clinic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
City of Hope Medical Center
University Hospital, Bordeaux
Barbara Ann Karmanos Cancer Institute
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
UNC Lineberger Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
University of Virginia
M.D. Anderson Cancer Center
University of Rochester
Fred Hutchinson Cancer Center
City of Hope Medical Center
University Health Network, Toronto
Fox Chase Cancer Center
City of Hope Medical Center
City of Hope Medical Center
OHSU Knight Cancer Institute
Dartmouth-Hitchcock Medical Center